Eli Lilly (LLY) Canada Inc. said it is disappointed and strongly disagrees with Canada’s Drug Agency’s Final Recommendation for Ebglyss, published on Friday, November 15, 2024. The CDA-AMC recommended ...
The reason for the disappointing sales, according to the company, is not an issue of demand or supply. During an earnings call Wednesday, Eli Lilly instead blamed it on drug wholesalers cutting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback